← FDA DRUG APPROVALS

FDA NDA · NDA019841

INDIUM IN 111 CHLORIDE

Sponsor: CURIUM

APPLICATION
NDA019841
TYPE
NDA
ORIGINAL APPROVAL
1994-09-27
LATEST ACTION
2017-01-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

INDIUM IN 111 CHLORIDE · ReferenceDiscontinued
INDIUM IN-111 CHLORIDE 5mCi/0.5ML · INJECTABLE · INJECTION

Approval history

2017-01-26Manufacturing (CMC) · Supplement 12 · standardAP
2002-02-19Labeling · Supplement 3 · standardLabelAP
1996-10-28Labeling · Supplement 1 · standardAP
1996-07-03Labeling · Supplement 2 · standardAP
1994-09-27Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →